UBM Canon's MPMN, the Global Authority on Cutting-Edge Technologies and Products to the Medical Device Industry, Announces Speci

LOS ANGELES, Nov. 16, 2011 /PRNewswire/ -- Medical Product Manufacturing News (MPMN), a UBM Canon world leading MedTech B2B publication and resource covering materials, components, equipment, and services for medical device design and development, has unveiled the special Web feature, "Five Pioneering Medical Products to Watch." Selected by MPMN editors, the five featured products represent industry trendsetters at various stages of development that could potentially revolutionize medical device design.

(Logo:  http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

"While there is no shortage of innovative medical devices currently in development, these five products really stand out as groundbreaking designs that, if commercialized, could overcome current end-use challenges and dramatically improve patient care," said Shana Leonard, editor-in-chief of Medical Product Manufacturing News.

High-profile medical devices from Abbott Laboratories and Medtronic Inc. are included on the list along with products in development at a startup company and two university labs. "Industry-leading companies such as Abbott Labs and Medtronic are constantly producing game-changing medical devices," Leonard said. "But some of the most exciting and out-of-the-box medical device breakthroughs are undeniably occurring in university labs as well."

View the featured medical products here.

About UBM Canon
UBM Canon, the leading B2B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM plc (UBM.L) a global provider of media and information services for professional B2B communities and markets.

SOURCE UBM Canon

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.